Hilton Munich City Hotel Munich, Germany12–13 May 2015

ArcheoloGIST Summit VIA 2-day scientific, interactive, case study-based meeting on the management of gastrointestinal stromal tumours (GIST)

This meeting is organised and funded by Pfizer © 2015 Pfizer GmbH. All rights reserved

Dec 2014. SUT14/143.

Invitation

www.pfizer.comARCHEOLOGIST

RESPICE • ADSPICE • PROSPICE

We are delighted to invite you to attend ArcheoloGIST Summit VI, an established Pfizer-sponsored initiative providing HCPs with a special interest in the management of GIST from across Europe, Africa and the Middle East with an educational and interactive forum to discuss recent developments in GIST.

Based upon an archaeological theme, the scientific principles of archaeology will be applied to GIST; ArcheoloGIST Summit VI will delve into the past (respice) to allow better understanding of the present (adspice) and future (prospice) management of patients with GIST.

Guided by an expert faculty, ArcheoloGIST Summit VI will provide delegates with the opportunity to exchange scientific research, share personal experiences and discuss key topics at the forefront of GIST management, including the characteristics of wild-type GIST and clinical research considerations for rare tumours. There will be a pathology masterclass on the latest developments in GIST diagnosis and interactive case study sessions will allow key learnings to be drawn from real-world patient cases. In addition, there will be a panel discussion on the current and future management of GIST.

Attendees are invited to submit their own GIST clinical cases to ArcheoloGIST Summit IV, and those selected by the faculty will be presented at the meeting and discussed with fellow attendees and the faculty. An award will be given for the case considered most clinically interesting, as voted for by the attendees and faculty.

We hope that you can join us for what promises to be a highly educational and engaging event.

Pfizer Oncology GI Team

FACULTYPaolo Casali (Co-chair)

Istituto Nazionale dei Tumori, Milan, Italy

Axel Le CesneInstitut Gustave Roussy, Villejuif, France

Angelo Paolo Dei TosGeneral Hospital of Treviso, Treviso, Italy

Peter Reichardt (Co-chair)HELIOS Klinikum Berlin-Buch, Berlin, Germany

Piotr RutkowskiMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

GUEST SPEAKERSRamesh Bulusu

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

George DemetriDana-Farber Cancer Institute, Boston, Massachusetts, USA

PROGRAMMEDay 1: Salı12 May13:00 Hoşgeldiniz ve karşılama

Pfizer Onkoloji ve Paolo Casali (İtalya)

13:15 Tema Konuşması George Demetri (ABD)

14:15 GIST yönetiminde son 12 aydaki gelişmelerPeter Reichardt (Almanya)

14:45 Kahve arası

15:00 Klinik vaka sunumu 1.oturumModerator: Piotr Rutkowski (Polonya)

16:15 Ustalık dersi : 2015’te GIST diyagnozu Angelo Paolo Dei Tos (İtalya)

16:45 Vahşi tip GIST: farklı bir VarlıkAngelo Paolo Dei Tos (İtalya)Piotr Rutkowski (Polonya)Ramesh Bulusu (Birleşik Krallık)

18:00 1.günün özetiPaolo Casali (İtalya)

18:15 Kapanış

19:30 Akşam yemeği

Day 2: ÇARŞAMBA 13 May 08:30 2.Güne Hoşgeldiniz

Peter Reichardt (Almanya)

08:45 Nadir tümörlerde klinik araştırmalarda ne düşünmeliyiz?Paolo Casali (İtalya)

09:15 Klinik vaka sunumu 2.oturumModeratör: Axel Le Cesne (Fransa)

10:45 Kahve arası

11:15 Panel: GIST yönetimi şimdi ve gelecek Moderatör Angelo Paolo Dei Tos (İtalya)

12:30 Vaka sunumları ödülüPfizer Onkoloji ve tüm konuşmacılar

13:00 Özet ve kapanışPeter Reichardt (Almanya)

13:15 Öğle yemeği

14:00 Ayrılış